A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody
A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody
Not yet recruiting · NCT07445815 · Registry updated 2026-03-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody | Infections, Mononegavirales infectious disease, RNA Virus Infections, Rhabdoviridae infectious disease, rabies, viral infectious disease | Not yet recruiting | Phase 2 | 2026-03-03 | NCT07445815 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lanzhou Institute of Biological Products Co., Ltd | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Lanzhou Institute of Biological Products Co., Ltd. | Lanzhou | China | 2 |